• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

AZ aims at Pfizer, GSK with potential new PARP cancer drug

cafead

Administrator
Staff member
  • cafead   Apr 14, 2021 at 09:42: AM
via AZ thinks it can improve on Lynparza, which works by inhibiting poly (ADP-ribose) polymerase (PARP), part of the specialist DNA damage repair system that cancer cells with BRCA and similar mutations rely on to survive.

article source
 

<